Haleon plc (NYSE:HLN) Increases Dividend to $0.12 Per Share

Haleon plc (NYSE:HLN) announced a — dividend on Monday, March 3rd, Wall Street Journal reports. Stockholders of record on Friday, April 25th will be given a dividend of 0.1166 per share on Thursday, June 5th. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, April 25th. This is an increase from Haleon’s previous — dividend of $0.05.

Haleon has a dividend payout ratio of 43.4% meaning its dividend is sufficiently covered by earnings. Analysts expect Haleon to earn $0.49 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 46.9%.

Haleon Trading Up 4.0 %

NYSE:HLN opened at $10.59 on Tuesday. The firm’s fifty day moving average is $9.59 and its 200-day moving average is $9.84. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon has a 52 week low of $7.89 and a 52 week high of $10.81. The firm has a market cap of $47.94 billion, a P/E ratio of 31.15, a P/E/G ratio of 2.82 and a beta of 0.28.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Equities analysts expect that Haleon will post 0.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HLN. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.